Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.

Εμφάνιση άλλων εκδόσεων (1)

OBJECTIVES: The use of clinical staging in the fatal neurodegenerative disease amyotrophic lateral sclerosis would have value in optimising future therapeutic trials. We aimed to use previous clinical trial data to determine the length of time patients spend in each of four proposed stages, its rang...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Balendra, R, Jones, A, Jivraj, N, Steen, I, Young, C, Shaw, P, Turner, M, Leigh, P, Al-Chalabi, A
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2015

Παρόμοια τεκμήρια

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
ανά: Balendra, R, κ.ά.
Έκδοση: (2015)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
ανά: Jones, A, κ.ά.
Έκδοση: (2014)

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
ανά: Balendra, R, κ.ά.
Έκδοση: (2014)

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
ανά: Jones, A, κ.ά.
Έκδοση: (2013)

Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System
ανά: Balendra, R, κ.ά.
Έκδοση: (2013)

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
ανά: Turner, M, κ.ά.
Έκδοση: (2002)

A proposed staging system for amyotrophic lateral sclerosis.
ανά: Roche, J, κ.ά.
Έκδοση: (2012)

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
ανά: Turner, M, κ.ά.
Έκδοση: (2007)

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
ανά: Al-Chalabi, A, κ.ά.
Έκδοση: (2003)

Biomarkers in amyotrophic lateral sclerosis.
ανά: Turner, M, κ.ά.
Έκδοση: (2009)

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease
ανά: Rutter-Locher, Z, κ.ά.
Έκδοση: (2016)

Amyotrophic lateral sclerosis
ανά: Leigh P Nigel, κ.ά.
Έκδοση: (2009-02-01)

Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients
ανά: Xueping Chen, κ.ά.
Έκδοση: (2018-06-01)

REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis
ανά: Turner, M, κ.ά.
Έκδοση: (2020)

Objectively monitoring amyotrophic lateral sclerosis patient symptoms during clinical trials with sensors: Observational study
ανά: Garcia-Gancedo, L, κ.ά.
Έκδοση: (2019)

Evolution of white matter damage in amyotrophic lateral sclerosis
ανά: Gabel, M, κ.ά.
Έκδοση: (2020)

Amyotrophic lateral sclerosis and cerebellum
ανά: Renata Kabiljo, κ.ά.
Έκδοση: (2022-07-01)

Young-onset amyotrophic lateral sclerosis: Historical and other observations
ανά: Turner, M, κ.ά.
Έκδοση: (2012)

Young-onset amyotrophic lateral sclerosis: historical and other observations.
ανά: Turner, M, κ.ά.
Έκδοση: (2012)

Quantifying disease progression in amyotrophic lateral sclerosis.
ανά: Simon, N, κ.ά.
Έκδοση: (2014)

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
ανά: Corcia P, κ.ά.
Έκδοση: (2012-08-01)

Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.
ανά: Johnston, C, κ.ά.
Έκδοση: (2006)

Clinical Controversies in Amyotrophic Lateral Sclerosis
ανά: Ruaridh Cameron Smail,, κ.ά.
Έκδοση: (2020-07-01)

Clinical psychology and amyotrophic lateral sclerosis
ανά: Francesco Pagnini, κ.ά.
Έκδοση: (2010-07-01)

Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study
ανά: Garcia-Gancedo, Luis, κ.ά.
Έκδοση: (2019-12-01)

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis
ανά: Henderson, R, κ.ά.
Έκδοση: (2018)

Evolution of white matter damage in amyotrophic lateral sclerosis
ανά: Matt C. Gabel, κ.ά.
Έκδοση: (2020-05-01)

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
ανά: Abrahams, S, κ.ά.
Έκδοση: (1997)

Amyotrophic lateral sclerosis.
ανά: Kiernan, M, κ.ά.
Έκδοση: (2011)

Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.
ανά: Scott, K, κ.ά.
Έκδοση: (2009)

Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis
ανά: Yildiz, O, κ.ά.
Έκδοση: (2025)

The reunification of amyotrophic lateral sclerosis
ανά: Turner, M
Έκδοση: (2018)

Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis.
ανά: Turner, M, κ.ά.
Έκδοση: (2011)

Neuroimaging in amyotrophic lateral sclerosis.
ανά: Turner, M, κ.ά.
Έκδοση: (2012)

The sex ratio in amyotrophic lateral sclerosis: A population based study.
ανά: Manjaly, Z, κ.ά.
Έκδοση: (2010)

Clinical neurorestorative progress in amyotrophic lateral sclerosis
ανά: Chen L, κ.ά.
Έκδοση: (2015-08-01)

Progress in clinical diagnosis of amyotrophic lateral sclerosis
ανά: Qiong YANG, κ.ά.
Έκδοση: (2012-06-01)

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
ανά: Kelly, M, κ.ά.
Έκδοση: (2020)

Amyotrophic lateral sclerosis: Clinical heterogeneity and approaches to classification
ανά: I. S. Bakulin, κ.ά.
Έκδοση: (2017-11-01)

Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.
ανά: Fang, F, κ.ά.
Έκδοση: (2013)